Suppr超能文献

前列腺癌的早期检测。日本一项基于前列腺特异性抗原的检测项目结果。

Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan.

作者信息

Egawa S, Suyama K, Ohori M, Kawakami T, Kuwao S, Hirokado K, Hirano S, Yokoyama E, Uchida T, Koshiba K

机构信息

Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.

出版信息

Cancer. 1995 Aug 1;76(3):463-72. doi: 10.1002/1097-0142(19950801)76:3<463::aid-cncr2820760317>3.0.co;2-a.

Abstract

BACKGROUND

Prostate cancer increasingly is becoming a medical problem in Japan. To maximize the chance for cure, extensive effort is being made to detect prostate cancer while confined to the gland.

METHODS

Determination was made of serum prostate specific antigen (PSA) in the early detection of prostate cancer in an Asian male population aged 55 years or older. Recommendation for biopsy was based solely on this parameter when its value exceeded 2.0 ng/ml in IMx immunoenzymetric assay.

RESULTS

Of 1189 men, 150 (12.6%) had elevated values. The proportion of males with serum PSA greater than 4.0 ng/ml was only 3.4%. Of the 99 males who underwent ultrasound-guided biopsies, 16 cancers were detected, a cancer detection rate of 1.3%. Most of these (81.3%) were clinically localized cancers. Seven patients with cancer had serum PSA levels below 4.0 ng/ml including 5 less than 3.0 ng/ml. These tumors would have been overlooked if the conventional cutoff levels of 4.0 ng/ml had been applied. Radical prostatectomy was conducted on 13 patients. All had histologic features of clinically significant cancer and 69.2% were pathologically confined within the gland.

CONCLUSIONS

Elderly Asian males appear to have lower serum PSA than their Western counterparts. The optimal cutoff of serum PSA for early detection should be examined further in Asian male populations. Differences in the incidence of prostate cancer between ethnic groups may have been overestimated in previous studies owing in part to unawareness by the physician and general public. Though the frequent use of more sophisticated diagnostic modalities will likely disclose greater numbers of prostate cancers in Japan, whether early detection reduces mortality by minimizing risk of death from cancer remains a point to be determined.

摘要

背景

前列腺癌在日本正日益成为一个医学问题。为了将治愈机会最大化,人们正在做出广泛努力,以便在前列腺癌局限于腺体时就进行检测。

方法

对55岁及以上亚洲男性人群进行前列腺癌早期检测时测定血清前列腺特异性抗原(PSA)。当IMx免疫酶测定法中PSA值超过2.0 ng/ml时,仅基于该参数进行活检推荐。

结果

在1189名男性中,150名(12.6%)PSA值升高。血清PSA大于4.0 ng/ml的男性比例仅为3.4%。在接受超声引导活检的99名男性中,检测到16例癌症,癌症检出率为1.3%。其中大多数(81.3%)为临床局限性癌症。7名癌症患者血清PSA水平低于4.0 ng/ml,其中5名低于3.0 ng/ml。如果应用4.0 ng/ml的传统临界值,这些肿瘤将会被漏诊。对13名患者进行了根治性前列腺切除术。所有患者均具有临床显著性癌症的组织学特征,69.2%在病理上局限于腺体。

结论

老年亚洲男性的血清PSA似乎低于西方男性。在亚洲男性人群中应进一步研究血清PSA用于早期检测的最佳临界值。种族群体之间前列腺癌发病率的差异在以往研究中可能被高估了,部分原因是医生和公众对此缺乏认识。尽管在日本频繁使用更先进的诊断方法可能会发现更多的前列腺癌,但早期检测是否通过将癌症死亡风险降至最低来降低死亡率仍是一个有待确定的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验